UBS Raises Plains All American Pipeline (PAA) Price Target to $31

UBS has reaffirmed its Buy rating on Plains All American Pipeline with a new target price of $31.00, a 21.74% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:23 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

UBS raised its price target on Plains All American Pipeline, L.P. ($PAA) to $31 from $30 on October 9, 2026, and rates the stock "Buy".

Since the rating, $PAA is up 3.7% after 1 week and up 3.7% to date (from the $24.34 close on Oct 9, 2026).

PAA Plains All American Pipeline, L.P.

$25.25 +46.72% year to date

Daily close · Oct 16, 2026

Key Points

On October 9, 2026, UBS reiterated its Buy rating on Plains All American Pipeline, L.P. (PAA) and raised its price target to $31.00 from $30.00.
UBS's $31 price target implies 21.74% upside from Plains All American Pipeline, L.P.'s ($PAA) current $25.46 share price.
Shares of PAA recently traded at $25.46, which is about 17.9% below UBS's new target price.
The company is scheduled to report its next earnings on November 4, 2026.

Get $PAA trade alerts by text

We text you when insiders, Congress or big funds trade $PAA. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Plains All American Pipeline, L.P. alert may contain errors. Disclosures

UBS has reiterated its Buy rating on Plains All American Pipeline, L.P. (PAA) on October 9, 2026, raising its price target from $30.00 to $31.00. This comes as the shares recently traded at $25.46, meaning they are about 17.9% below the new target price.

Other Institutional Activity in Plains All American Pipeline

Alps Advisors Inc. trimmed its holdings by 2,595,267 shares, bringing its total to 70,510,853 shares worth about $1.78 billion. Invesco Ltd. also reduced its position, selling 60,096 shares for a total of 33,326,777 shares valued at approximately $841.5 million. Meanwhile, Blackstone Inc. grew its stake by 1,443,013 shares, ending with 20,183,446 shares worth about $509.6 million.

Plains All American Pipeline, L.P. Stock Up 0.4%

PAA shares are currently trading below their target price, which suggests potential upside if the stock moves closer to UBS's target of $31.00. The recent trading price is significantly lower than the target, indicating that the market may not fully reflect the company's growth prospects.

12-month forecast

$PAA price target

Plains All American Pipeline, L.P. daily closes and this analyst's $31 target. Not advice.

Recent Earnings

For the trailing twelve months, Plains All American Pipeline reported a revenue of $52.3 billion and an EPS of $1.17. The company has shown a year-over-year revenue growth of 66.3% and a net margin of 5.3%. Its return on equity stands at 10.2%. The next earnings report is set for November 4, 2026.

Insider Buying and Selling at Plains All American Pipeline, L.P.

On June 29, 2026, Director Lawrence Michael Ziemba sold 2,346 shares at an average price of $21.95, totaling about $51,495. This transaction occurred before the recent analyst updates.

Analysts Set New Price Targets

On the same day as UBS's update, Jefferies initiated coverage on PAA with a Buy rating and a price target of $27.00. Earlier on September 21, UBS maintained its Buy rating with a target of $31.00, while Barclays kept an Underweight rating with a target of $24.00, and Mizuho maintained an Outperform rating with a target of $30.00.

About Plains All American Pipeline

Plains All American Pipeline, L.P. is based in Houston, TX, and operates in the energy sector, specifically in oil and gas midstream. The company transports, stores, and gathers crude oil and natural gas liquids primarily in the United States and Canada. This analyst rating update comes as the company prepares for its next earnings report, which could provide more insights into its financial performance.

Bottom Line

Investors should keep an eye on Plains All American Pipeline as it approaches its next earnings date on November 4, 2026. With UBS's recent reiteration of a Buy rating and a target price increase, the stock could have potential for growth if it aligns more closely with analyst expectations.